Invention Grant
- Patent Title: E. coli strains having an oxidative cytoplasm
-
Application No.: US17282842Application Date: 2019-11-07
-
Publication No.: US11407975B2Publication Date: 2022-08-09
- Inventor: Daniel Groff
- Applicant: Sutro Biopharma, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Sutro Biopharma, Inc.
- Current Assignee: Sutro Biopharma, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Kilpatrick Townsend & Stockton LLP
- International Application: PCT/US2019/060345 WO 20191107
- International Announcement: WO2020/097385 WO 20200514
- Main IPC: C12N1/20
- IPC: C12N1/20 ; C12N9/90 ; C12N9/02 ; C12N15/52 ; C07K16/32 ; C12N9/12 ; C12N9/00 ; C12N15/70

Abstract:
This disclosure provides an E. coli strain, which lacks thioredoxin reductase activity encoded by trxB and thioredoxin 1 activity encoded by trxA, and glutathione reductase activity encoded by gor. Said E. coli strain expresses a mutated AhpC protein having glutathione reductase activity and a cytosolic prokaryotic disulfide isomerase. The E. coli strain has an oxidative cytosol and can be used to efficiently produce proteins having disulfide bonds.
Public/Granted literature
- US20210348118A1 E. COLI STRAINS HAVING AN OXIDATIVE CYTOPLASM Public/Granted day:2021-11-11
Information query
IPC分类: